Trial intelligence / Profile preview

Long-term comparison of DMPA, levonorgestrel implant, and copper IUD effects on depression and sexual function

PACTR201801002743482Not yet recruiting

Sponsor
Effective Care Research Unit
Start
Nov 2017
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of medroxyprogesterone acetate and avatrombopag in major depressive disorder (MDD) and sexual dysfunction, sponsored by Effective Care Research Unit. Planned start Nov 2017; status: not yet recruiting.

02

Drugs

medroxyprogesterone acetateavatrombopag
03

Conditions

major depressive disorder (MDD)sexual dysfunction

Beyond the preview

Go deeper on PACTR201801002743482.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR201801002743482.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call